iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
66 hedge funds and large institutions have $48.8M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
Holders
66
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.6M | |
| 2 | +$2.06M | |
| 3 | +$1.23M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$921K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$422K |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$1.51M | |
| 3 | -$880K | |
| 4 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$285K |
| 5 |
PP
Prudential plc
London, England,
United Kingdom
|
-$247K |